The release of basogranulin in response to IgE-dependent and IgE-independent stimuli: Validity of basogranulin measurement as an indicator of basophil activation

Journal of Allergy and Clinical Immunology

Volumn 112, Issue 1, 2003, Pages 102-108

  Mochizuki, Akinori ^a   McEuen, Alan R ^a   Buckley, Mark G ^a   Walls, Andrew F ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

A23187; Basogranulin; Basophil; BB1; C5a; f Met Leu Phe; Histamine; IgE; Nonreleaser; Wortmannin

Indexed keywords

BASOGRANULIN; COMPLEMENT COMPONENT C5A; FC RECEPTOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; PROTEIN; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; BASOPHIL; CELL ACTIVATION; CELL ISOLATION; CELL STIMULATION; CONCENTRATION RESPONSE; DOT HYBRIDIZATION; FLOW CYTOMETRY; FLUOROMETRY; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOASSAY; MAST CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION;

EID: 0038676212     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1511     Document Type: Article

References (40)

1. Kobayashi H, Ishizuka T, Okayama Y. Human mast cells and basophils as sources of cytokines. Clin Exp Allergy 2000;30:1205-12.
2. Walls AF, He S, Buckley MG, McEuen AR. Roles of the mast cell and basophil in asthma. Clin Exp Allergy Reviews 2001;1:68-72.
3. Fureder W, Agis H, Wiltheim M, Bankl HC, Maier U, Kishi K, et al. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/CSaR expression on skin mast cells. J Immunol 1995;155:3152-60.
4. Church MK, Bradding P, Walls AF, Okayama Y. Human mast cells and basophils. In: Kay AB, editor. Allergy and allergic disease. Vol. 1. Oxford: Blackwell Science; 1997. p. 149-70.
5. MacGlashan D, Jr, Gauvreau G, Schroeder JT. Basophils in airway disease. Curr Allergy Asthma Rep 2002;2:126-32.
6. Charlesworth EN, Hood AF, Soter NA, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest 1989;83:1519-26.
7. Liu MC, Hubbard WC, Proud D, Stealey BA, Galli SJ, Kagey-Sobotka A, et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis 1991;144:51-8.
8. Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988;81:580-9.
9. Kepley CL, Craig SS, Schwartz LB. Identification and partial characterization of a unique marker for human basophils. J Immunol 1995;154:6548-55.
10. McEuen AR, Buckley MG, Compton SJ, Walls AF. Development and characterization of a monoclonal antibody specific for human basophils and the identification of a unique secretory product of basophil activation. Lab Invest 1999;79:27-38.
11. McEuen AR, Calafat J, Compton SJ, Easom NJ, Buckley MG, Knol EF, et al. Mass, charge, and subcellular localization of a unique secretory product identified by the basophil-specific antibody BB1. J Allergy Clin Immunol 2001;107:842-8.
12. Irani AM, Huang C, Xia HZ, Kepley C, Nafie A, Fouda ED, et al. Immunohistochemical detection of human basophils in late-phase skin reactions. J Allergy Clin Immunol 1998;101:354-62.
13. Kepley CL, McFeeley PJ, Oliver JM, Lipscomb MF. Immunohistochemical detection of human basophils in postmortem cases of fatal asthma. Am J Respir Crit Care Med 2001;164:1053-8.
14. Wilson DR, Irani AM, Walker SM, Jacobson MR, Mackay IS, Schwartz LB, et al. Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium. Clin Exp Allergy 2001;31:1705-13.
15. Ying S, Robinson DS, Meng Q, Barata LT, McEuen AR, Buckley MG, et al. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES). J Immunol 1999;163:3976-84.
16. Macfarlane AJ, Kon OM, Smith SJ, Zeibecoglou K, Kahn LN, Barata LT, et al. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol 2000;105:99-107.
17. KleinJan A, McEuen AR, Dijkstra MD, Buckley MG, Walls AF, Fokkens WJ. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation. J Allergy Clin Immunol 2000;106:677-86.
18. Braunstahl GJ, Overbeek SE, Fokkens WJ, Kleinjan A, McEuen AR, Walls AF, et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001;164:858-65.
19. Gilbert HS, Ornstein L. Basophil counting with a new staining method using alcian blue. Blood 1975;46:279-86.
20. Skov PS, Mosbech H, Norn S, Weeke B. Sensitive glass microfibre-based histamine analysis for allergy testing in washed blood cells. Results compared with conventional leukocyte histamine release assay. Allergy 1985;40:213-8.
21. Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM. Syk deficiency in nonreleaser basophils. J Allergy Clin Immunol 1999;104:279-84.
22. Lichtenstein LM. The mechanism of basophil histamine release induced by antigen and by the calcium ionophore A23187. J Immunol 1975;114:1692-9.
23. Gibbs BF, Grabbe J. Inhibitors of PI 3-kinase and MEK kinase differentially affect mediator secretion from immunologically activated human basophils. J Leukoc Biol 1999;65:883-90.
24. Tedeschi A, Lorini M, Galbiati S, Gibelli S, Miadonna A. Inhibition of basophil histamine release by tyrosine kinase and phosphatidylinositol 3-kinase inhibitors. Int J Immunopharmacol 2000;22:797-808.
25. Miura K, MacGlashan DW. Phosphatidylinositol-3 kinase regulates p21ras activation during IgE- mediated stimulation of human basophils. Blood 2000;96:2199-205.
26. Benhamou M, Ryba NJ, Kihara H, Nishikata H, Siraganian RP. Protein-tyrosine kinase p72syk in high affinity IgE receptor signaling. Identification as a component of pp72 and association with the receptor gamma chain after receptor aggregation. J Biol Chem 1993;268:23318-24.
27. Dvorak AM. Ultrastructural localization of histamine in human basophils and mast cells; changes associated with anaphylactic degranulation and recovery demonstrated with a diamine oxidase-gold probe. Allergy 1997;52:14-24.
28. Monneret G, Benoit Y, Debard AL, Gutowski MC, Topenot I, Bienvenu J. Monitoring of basophil activation using CD63 and CCR3 in allergy to muscle relaxant drugs. Clin Immunol 2002;102:192-9.
29. Platz IJ, Binder M, Marxer A, Lischka G, Valent P, Buhring HJ. Hymenoptera-venom-induced upregulation of the basophil activation marker ecto-nucleotide pyrophosphatase/phosphodiesterase 3 in sensitized individuals. Int Arch Allergy Immunol 2001;126:335-42.
30. Kikuchi Y, Kaplan AP. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 2001;107:1056-62.
31. Bochner BS. Systemic activation of basophils and eosinophils: markers and consequences. J Allergy Clin Immunol 2000;106:S292-302.
32. Winther L, Moseholm L, Reimert CM, Stahl Skov P, Kaergaard Poulsen L. Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis. Allergy 1999;54:436-45.
33. Lin RY, Schwartz LB, Curry A, Pesola GR, Knight RJ, Lee HS, et al. Histamine and tryptase levels in patients with acute allergic reactions: An emergency department-based study. J Allergy Clin Immunol 2000; 106:65-71.
34. Andersson M, Nolte H, Olsson M, Skov PS, Pipkorn U. Measurement of histamine in nasal lavage fluid: comparison of a glass fiber-based fluorometric method with two radioimmunoassays. J Allergy Clin Immunol 1990;86:815-20.
35. Asero R, Tedeschi A, Lorini M, Salimbeni R, Zanoletti T, Miadonna A. Chronic urticaria: novel clinical and serological aspects. Clin Exp Allergy 2001;31:I 105-10.
36. Nissen D, Petersen LJ, Nolte H, Permin H, Melchior N, Skov PS. Measurement of histamine release from human lung tissue ex vivo by microdialysis technique. Inflamm Res 1998;47:50I-5.
37. O'Sullivan S, Dahlen B, Dahlen SE, Kumlin M. Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol 1996;98:421-32.
38. 12 tryptase level as a marker of allergic airway inflammation in asthma. J Asthma 2002;39:315-22.
39. D2 by human helper T cell subsets. J Immunol 2000;164:2277-80.
40. Foster B, Schwartz LB, Devouassoux G, Melcalfe DD, Prussin C. Characterization of mast-cell tryptase-expressing peripheral blood cells as basophils. J Allergy Clin Immunol 2002;109:287-93.